logo
17,096 Kiwis Call For Urgent Action To Fund Keytruda For New Zealand's 'deadliest Breast Cancer'

17,096 Kiwis Call For Urgent Action To Fund Keytruda For New Zealand's 'deadliest Breast Cancer'

Scoop18-06-2025
Breast Cancer Foundation NZ is proud to support Auckland woman, Catherine Cooke, as she presents her petition to MP Hon. Mark Mitchell, urging the Government to fund the cancer drug Keytruda for early stage triple negative breast cancer (TNBC). Catherine is presenting the petition at Breast Cancer Foundation NZ office in Parnell on 27 June at 2pm. The level of support for this petition is significant and shows New Zealanders are fed up with falling behind the rest of the world in terms of access to life-saving treatment.
Catherine was diagnosed with early TNBC, an aggressive form of breast cancer in November last year after her yearly mammogram. She was told Keytruda with chemotherapy would give her the best chance of survival – but the drug would only be funded if her cancer was advanced. Instead, Catherine has had to put most of her work on hold and sell her family home to fund the treatment - which is costing around $85,000.
Around 350 women are diagnosed with triple negative breast cancer every year, which is approximately 10% of all breast cancer diagnoses. It is also more common in younger women with nearly 15% of diagnoses in women under the age of 45 being triple negative.
For one in three women with early triple negative breast cancer, it will return and become incurable within five years. It is the deadliest form of breast cancer and is harder to treat. Unlike most other breast cancers, triple negative breast cancer doesn't respond to hormone-blocking treatments and targeted drugs.
Keytruda is an immunotherapy drug, and it is the only targeted treatment that works to fight triple negative breast cancer and is given to patients alongside chemotherapy. It's fully funded in 40 other countries including Australia, Canada and Britain. New international research was published last year and showed that Keytruda can stop women dying from triple negative breast cancer because it's highly effective at preventing cancer coming back.
Patients with early triple negative breast cancer receiving Keytruda in a clinical trial were 34% less likely to die and 32% less likely to have their cancer spread beyond the breast. It is widely accepted by the medical community internationally as the best drug to treat early triple negative breast cancer and New Zealanders deserve access to this treatment.
Breast Cancer Foundation NZ Chief Executive, Ah-Leen Rayner said 'women like Catherine are having to go through drastic lengths to be able to pay for Keytruda. It's atrocious that New Zealanders are selling their homes, asking for help from their parents or complete strangers to find hundreds of thousands of dollars, or potentially simply going without treatment that could save their lives.
'We are so grateful to Catherine for working tirelessly for better drug access for New Zealanders in the future, but she shouldn't have to. We're urging the government to ensure Pharmac has the budget it needs to fund these essential medicines that are standard of care around the world.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Pandemic Perspectives Focus Of COVID-19 Inquiry Public Hearing Next Week
Pandemic Perspectives Focus Of COVID-19 Inquiry Public Hearing Next Week

Scoop

time10 hours ago

  • Scoop

Pandemic Perspectives Focus Of COVID-19 Inquiry Public Hearing Next Week

The Royal Commission of Inquiry into COVID-19 Lessons Learned will next week hear a range of perspectives on the pandemic as the Inquiry's first public hearing begins. The Inquiry's 'Pandemic Perspectives' public hearing will take place between Monday 7 July and Friday 11 July. This hearing will allow Commissioners to hear from groups, organisations, and individuals from around Aotearoa New Zealand about their experiences of the pandemic and the Government's response to COVID-19. 'The Pandemic Perspectives public hearing will allow us, in the open, to hear a range of experiences as well as suggestions for future pandemic responses. It is important we listen to these voices and ask key questions, so we can develop robust findings and recommendations,' says Grant Illingworth KC, Chair of the Inquiry. Individuals, organisations and experts will talk about the effects of key public health decisions, including social division and isolation, health and education, and business activity. Commissioners are focusing the hearing on three key areas of the Inquiry's terms of reference and that have been key themes raised in public submissions already received by the Inquiry: · Lockdowns in 2021, in particular the extended lockdown in Auckland and Northland from September 2021. · Vaccine approvals and safety. · Introduction and use of vaccine mandates throughout 2021 and 2022. The hearing schedule and list of witnesses is available on the Inquiry's website: A second and final public hearing will take place from 20 August to 27 August in Pōneke Wellington, where Commissioners will hear from key decision makers who led the Government's response to the COVID-19 pandemic, and from senior public servants. 'As Commissioners, our job is to identify lessons from the country's COVID-19 response to ensure that as a nation, we can be better prepared for future pandemics,' says Mr Illingworth. 'Our goal is to provide recommendations – that can be understood by all New Zealanders – to help build a strong response for the future. 'We need a well-organised, resilient, robust defence, and we need to be able to come together as a country to face future pandemics.' Alongside the public hearings, the Inquiry has also held interviews with key decision makers, met with individuals and organisations who experienced the pandemic and the response to it, gathered 31,000 public submissions, and sought extensive written evidence from Government departments and other organisations. 'We are encouraged by and thank the 31,000 of you who shared your experiences through our recent public submissions process. I also thank the huge number of people and organisations we've met in engagements up and down the country. Your experiences and perspectives are vital to our work,' says Mr Illingworth. The 'Pandemic Perspectives' public hearing will be streamed on the Inquiry's website so it can be watched live by the public. Registered media will be able to attend the hearing for reporting purposes. A range of accessible resources will also be available during and after the hearings. Due to physical limitations, the Inquiry cannot accommodate members of the public.

Nursing Students Ready To Walk
Nursing Students Ready To Walk

Scoop

time11 hours ago

  • Scoop

Nursing Students Ready To Walk

Concerning interim findings of the New Zealand Nurses Organisation Tōpūtanga Tapuhi Kaitiaki o Aotearoa (NZNO) 2025 Student Survey has found most students will go overseas if they can't get jobs in New Zealand. This comes as Te Whatu Ora refused to address NZNO claims around its obligation to employ new graduates in collective agreement negotiations. The survey was completed by 1246 nursing students, and NZNO National Student Unit Co-chair Bianca Grimmer said the results were crystal clear - "hire us or we will leave". "The survey shows 61.86% of students were considering seeking a nursing job overseas if they were unable to get a new graduate job in Aotearoa New Zealand. This increased to 73% of Māori respondents. "This is a significant potential loss of our domestic nursing workforce." Finances remained a significant issue for all students and was linked to high levels of stress by 80.39% of respondents, Bianca Grimmer said. "An increased fear of not getting work is exacerbated by most students' money concerns issues, many of whom depend on funding from student loans for their survival. "We have a health system in crisis. At a time when we desperately need more homegrown nurses, the Government and nursing schools really need to do more to encourage students to stay in their studies and come out well and ready to nurse." At least 35.61% of respondents said they did not work in paid employment and 61.58% of respondents had to significantly reduce their paid work hours during placement, she said. "Paying all students the minimum or living wage while on clinical placements would make a massive difference to graduate numbers. Nursing students need assistance while they study." NZNO Te Rūnanga Tauira chair Davis Ferguson said Māori and Pacific students are essential, and better cultural support in nurse training would result in a health system that better meets the needs of Māori and Pacific peoples. "The lack of appropriate cultural support in nursing studies is an issue the Government and training providers need to urgently address." The full findings of the survey will be made available on the NZNO website later this year.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store